Paradigm Biopharmaceuticals Ltd (Administrators Appointed) (ASX:PAR) has advised that 116,360,866 quoted options trading under ASX code PAROB will expire at 5.00pm AEDT on 21 October 2026, with the company's joint and several voluntary administrators confirming they will not accept or process any notices of exercise during the administration period.

Key Points

  • 116,360,866 PAROB listed options will expire at 5.00pm AEDT on 21 October 2026
  • Administrators Christopher Pattinson and Hayden White of FTI Consulting will not process option exercise notices or issue shares or piggyback options during the administration
  • Official ASX quotation of the options will cease at close of trading on 15 October 2026; options have been suspended from quotation since 23 September 2026
  • Each option carries an exercise price of $0.2375 and, if exercised, would entitle the holder to one fully paid ordinary share and one piggyback option exercisable at $0.38 on or before 30 April 2029
  • Any exercise monies received will be held separately on trust and returned to the relevant holder without interest

Administrator Decision on PAROB Option Exercises

Joint and several voluntary administrators Christopher Pattinson and Hayden White of FTI Consulting (Australia) Pty Limited have determined that, during the administration of Paradigm Biopharmaceuticals, they cannot accept or process notices of exercise of the PAROB options. As a result, the administrators will not issue fully paid ordinary shares or piggyback options exercisable at $0.38 on or before 5.00pm AEST on 30 April 2029 upon exercise. The administrators stated this decision was made having regard to the interests of the company's creditors, option holders and broader stakeholders, including uncertainty as to the future of the company and its securities while in administration.

Quotation Cessation and Option Lapse Details

Official quotation of the PAROB options on ASX will cease at the close of trading on 15 October 2026, being four business days before the Expiry Date of 21 October 2026. The filing notes the options have been suspended from quotation since 23 September 2026 and will not trade on ASX before quotation ceases. Any options that have not been exercised will lapse at 5.00pm AEDT on 21 October 2026. Any notices of exercise submitted will not be processed, and any exercise monies received will be held separately on trust for the relevant holder and returned promptly without interest.

Share Price and Option Terms Disclosed in Filing

According to the filing, the last market price of Paradigm shares on ASX was $0.245 on 18 September 2026, the last trading day before the company's securities were suspended. During the three months preceding the date of the filing, the highest market sale price of shares on ASX was $0.295 on 11 September 2026, and the lowest market sale price was $0.1575 on 30 July 2026. The total number of options is 116,360,866, each with an exercise price of $0.2375. The filing also states that no underwriting agreement exists in respect of the options.